Johnson & Johnson (JNJ) is among the 11 Dogs of the Dow Dividend Stocks to Buy Now, showcasing its defensive strength in the market. In the second quarter of 2025, JNJ reported a revenue of $23.7 billion, a 5.77% growth from the previous year, leading to an increase in full-year sales outlook by $2 billion. The company also raised its earnings per share forecast. JNJ expects accelerated growth in the latter half of the year with significant approvals and regulatory submissions in key areas. With a strong dividend policy and a quarterly dividend of $1.30 per share, JNJ is a favored investment option.

Read more at Yahoo Finance: Johnson & Johnson’s (JNJ) Defensive Strength Shines Among the Dogs of the Dow